The Efficacy of Integrated Behavioral Therapy for Selective Mutism

Status Completed

Clinical Trial Summary

This study examines the efficacy of the Integrated Behavioral Therapy for Selective Mutism protocol (Bergman et al., 2013). Participants are 60 children, aged 4-8 years, diagnosed with Selective Mutism (SM). The level of SM symptoms is assessed during first arrival to the SM unit of Schneider Children's Medical Center of Israel (Intake), at the first treatment session, at sessions 12, and at the end of treatment. A secondary aim of this study is to assess the contribution of parent's characteristics (anxiety and depression levels, parenting style) to the childrens' SM symptoms level and to treatment achievements.

Clinical Trial Description

All study procedures have been approved by the Institutional Review Board of Schneider Children's Medical Center of Israel. Participants are recruited from the Selective Mutism unit at Schneider Children's Medical Center of Israel, during their first visit to the clinic. Both parents of eligible children sign informed consents. Each child is evaluated by a clinical psychologist, using a semi-structured interview (ADIS), designed to diagnose the child and to determine the level of symptom severity. The parents who are identified as the main-caregiving, complete questionnaires assessing the child's levels of SM symptoms and social anxiety (SMQ, SASC), the parents' levels of social anxiety (LSAS, SPIN) and depression (BDI), parent's authority style (PAQ), parental accommodation (FASA) and parental playfulness (PPQ). The child's teacher completes questionnaires assessing the child's SM levels (SSQ). Participants are than assigned either to the treatment or the waiting list group (by chance). The assessment of SM levels is repeated in both groups at 1 week from baseline, 12 weeks from baseline, and 24 weeks from baseline. participants of the waiting list group will commence treatment following the 24 weeks waiting period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04585048
Study type	Interventional
Source	Rabin Medical Center
Contact
Status	Completed
Phase	N/A
Start date	May 14, 2017
Completion date	March 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02554929` - Treatment of Social Anxiety Disorder and Selective Mutism	N/A
Completed	`NCT00554749` - What Treatment Works for Children With Selective Mutism?	N/A
Completed	`NCT04291638` - Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism	N/A
Completed	`NCT01002196` - Randomised Controlled Treatment Study of Selective Mutism	Phase 2
Completed	`NCT02009839` - Web-Based CBT Protocol for Treatment of Selective Mutism	N/A
Recruiting	`NCT03528109` - Improving Access to Child Anxiety Treatment	N/A
Completed	`NCT02051192` - Brief Behavioral Treatment for Anxiety in Young Children	Phase 1/Phase 2
Completed	`NCT00458198` - Integrated Behavioral Therapy for Treating Children With Selective Mutism	N/A
Completed	`NCT05378711` - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine	Phase 2
Completed	`NCT03612102` - Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism	N/A
Completed	`NCT04233905` - Factors Influencing Selective Mutism